The importance of protein kinase G (PKG) for cGMP-dependent cell death and neuroprotection in inherited retinal neurodegeneration
The importance of protein kinase G (PKG) for cGMP-dependent cell death and neuroprotection in inherited retinal neurodegeneration
批准号:
212312876
负责人:
Professor Dr. Francois Paquet-Durand
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2012
资助国家:
德国
项目状态:
已结题
起止时间:
2011-12-31 至 2014-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Retinitis Pigmentosa (RP) is a group of inherited retinal degenerations which constitutes one of the leading causes of blindness in the developed world. These are at present untreatable and the underlying neurodegenerative mechanisms are unknown even though the genetic causes are often established. Since elevated levels of cyclic guanosine monophosphate (cGMP) are responsible for photoreceptor cell death in different animal models for human RP, differential regulation of factors involved in cGMP signalling may represent a novel approach for the treatment of RP. The aim of this study is to investigate cGMP-signalling and its role in photoreceptor degeneration using in vivo, ex vivo, and in vitro techniques. The project will focus on the activity of cGMPdependent protein kinase G (PKG), its potential targets during retinal degeneration, and the identification of neuroprotective strategies to halt or delay processes leading to blindness. This will be accomplished by in vivo phenotyping of treated and untreated mice of the lines studied, and the follow-up of degenerative events in the same individual animals using state-of-the-art, non invasive technology for both functional and morphological characterization. At certain time points, a number of animals will be sacrificed for ex vivo studies with emphasis on assessing metabolic activity of calpains, poly-ADP-ribose-polymerase (PARP), and histone deacetylases (HDAC) as potential downstream effectors of cGMP-PKG. New data on processes active during retinal neurodegeneration will serve as basis for developing and testing novel experimental treatments on in vitro retinal explants, and where applicable, in vivo.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Developing nanocapsules for the targeted drug delivery to the neuroretina
-
批准号:426861724
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Professor Dr. Francois Paquet-Durand
-
依托单位:
Targeting CNG-Ca2+ channels: Evaluation of pharmacological and antisense oligonukleotide approaches for the treatment of retinitis pigmentosa.
-
批准号:384355007
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Professor Dr. Francois Paquet-Durand
-
依托单位:
Vergleichende Studie von Zelltodmechanismen in rd1 und Cpfl1 Photorezeptoren
-
批准号:80463681
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Professor Dr. Francois Paquet-Durand
-
依托单位:
国内基金
海外基金
登录
查看更多内容
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
-
批准号:82371660
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:魏喆
-
依托单位:
抑制Protein Kinase D促进胚胎干细胞自我更新的分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:叶守东
-
依托单位:
AMPK介导的RIPK1磷酸化在能量压力引起的细胞死亡中的作用与机制研究
-
批准号:32070737
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:许代超
-
依托单位:
Caspase8和RIP3调控细胞程序性坏死的关键机制研究
-
批准号:31970688
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:章海兵
-
依托单位:
ZBP1细胞程序性坏死信号通路的调控机制研究
-
批准号:31970690
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2019
-
负责人:张四清
-
依托单位:
Spata16基因在小鼠精子发生过程中的作用机理研究
-
批准号:81100460
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:黄卫人
-
依托单位:
PICK1对心脏局部交感神经递质的平衡调控机制研究
-
批准号:31000472
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2010
-
负责人:靳文英
-
依托单位:
CAPK介导的Smac释放机制研究
-
批准号:31070670
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:金英花
-
依托单位:
脐带血HSCs扩增的新策略:抑制"ROS-P38MAPK-HSCs衰老"信号通路
-
批准号:30871097
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:刘凌波
-
依托单位:
CaMK II信号转导通路参与前扣带回皮质调节IBS大鼠的内脏痛觉
-
批准号:30800512
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:曹芝君
-
依托单位: